Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Laryngeal Neoplasms 1Gliosarcoma 1Glioblastoma 1Brain Neoplasms 1Adrenocortical Carcinoma 1

Interventions

Cisplatin 9Cetuximab 6Radiotherapy, Intensity-Modulated 5Docetaxel 4Radiotherapy 3Fluorouracil 3Carboplatin 3pembrolizumab 2durvalumab 2Radiation 2Hydroxyurea 2Drug Therapy 2Celecoxib 2Bupropion 2130-nm albumin-bound paclitaxel 21,2-diaminocyclohexaneplatinum II citrate 2sodium thiosulfate 1gossypol acetic acid 1Varenicline 1Transcutaneous Electric Nerve Stimulation 1Tobacco Use Cessation Devices 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Platinum 1Pilocarpine 1Oral Hygiene 1Nicotine Replacement Therapy 1Nicotine 1NVP-BKM120 1Immunoglobulin G 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Laryngeal Neoplasms × gossypol acetic acid × Clear all
NCT01633541 2023-07-20

Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer

University of Michigan Rogel Cancer Center

Phase 2 Completed
55 enrolled 15 charts
Head & Neck

Laryngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡